Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8096816rdf:typepubmed:Citationlld:pubmed
pubmed-article:8096816lifeskim:mentionsumls-concept:C0022271lld:lifeskim
pubmed-article:8096816lifeskim:mentionsumls-concept:C0686347lld:lifeskim
pubmed-article:8096816lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8096816lifeskim:mentionsumls-concept:C0439611lld:lifeskim
pubmed-article:8096816lifeskim:mentionsumls-concept:C1709269lld:lifeskim
pubmed-article:8096816pubmed:issue3lld:pubmed
pubmed-article:8096816pubmed:dateCreated1993-5-7lld:pubmed
pubmed-article:8096816pubmed:abstractTextTardive dyskinesia (TD) is an iatrogenic syndrome caused by long-term treatment with neuroleptics and is characterized by abnormal involuntary movements in the orofacial region, lingual dyskinesia and in some cases dyskinesia also in the extremities, head and trunk. In the present study we found 20% TD in chronic-neuroleptic-treated patients with a significantly greater prevalence in females (27% of the total population), and a higher frequency in older patients. In males, patients who received electroconvulsive therapy had a significantly lower prevalence of TD. 23 patients had seizures; 7 of these suffered from TD, all of them female.lld:pubmed
pubmed-article:8096816pubmed:languageenglld:pubmed
pubmed-article:8096816pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096816pubmed:citationSubsetIMlld:pubmed
pubmed-article:8096816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8096816pubmed:statusMEDLINElld:pubmed
pubmed-article:8096816pubmed:issn0014-3022lld:pubmed
pubmed-article:8096816pubmed:authorpubmed-author:SchwartzMMlld:pubmed
pubmed-article:8096816pubmed:authorpubmed-author:TaiJJlld:pubmed
pubmed-article:8096816pubmed:authorpubmed-author:SharpHHlld:pubmed
pubmed-article:8096816pubmed:authorpubmed-author:SilverHHlld:pubmed
pubmed-article:8096816pubmed:issnTypePrintlld:pubmed
pubmed-article:8096816pubmed:volume33lld:pubmed
pubmed-article:8096816pubmed:ownerNLMlld:pubmed
pubmed-article:8096816pubmed:authorsCompleteYlld:pubmed
pubmed-article:8096816pubmed:pagination264-6lld:pubmed
pubmed-article:8096816pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:meshHeadingpubmed-meshheading:8096816-...lld:pubmed
pubmed-article:8096816pubmed:year1993lld:pubmed
pubmed-article:8096816pubmed:articleTitleTardive dyskinesia in northern Israel: preliminary study.lld:pubmed
pubmed-article:8096816pubmed:affiliationDepartment of Neurology, Faculty of Medicine, Bnai Zion Medical Center, Acre, Israel.lld:pubmed
pubmed-article:8096816pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8096816pubmed:publicationTypeComparative Studylld:pubmed